A Phase II Study of Neratinib in Metastatic HER2 Non-amplified by HER2 Mutant Breast Cancer

Administered By

Duke Cancer Institute

Awarded By

Washington University

Contributors

Kimmick, Gretchen Genevieve Principal Investigator

Start/End

January 1, 2014 - December 31, 2022